MOLECULAR DETERMINANTS OF PRIONOID DOMAINS FROM FUNCTIONAL VERSUS PATHOLOGICAL AMYLOIDS: TOWARDS THE DEVELOPMENT OF INHIBITORS WITH THERAPEUTIC APPLICATIONS